Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
---|---|---|---|---|
Revenue | 575.18 | 514.62 | 322.35 | 355.07 |
yoy growth (%) | 11.76 | 59.64 | -9.21 | -5.42 |
Raw materials | -375.96 | -336.68 | -176.8 | -205.42 |
As % of sales | 65.36 | 65.42 | 54.84 | 57.85 |
Employee costs | -43.74 | -35.88 | -33.78 | -27.82 |
As % of sales | 7.6 | 6.97 | 10.48 | 7.83 |
Other costs | -86.64 | -95.18 | -68.69 | -78.26 |
As % of sales (Other Cost) | 15.06 | 18.49 | 21.31 | 22.04 |
Operating profit | 68.82 | 46.86 | 43.06 | 43.56 |
OPM | 11.96 | 9.1 | 13.35 | 12.26 |
Depreciation | -32.57 | -34.28 | -31.05 | -32.72 |
Interest expense | 0 | -12.72 | -13.04 | -34.97 |
Other income | 8.42 | 17.76 | 3.57 | 0.72 |
Profit before tax | 44.67 | 17.61 | 2.54 | -23.42 |
Taxes | 4.31 | 13.21 | -1.96 | -3.16 |
Tax rate | 9.66 | 74.98 | -77.04 | 13.49 |
Minorities and other | 0 | 0 | 0 | 0 |
Adj. profit | 48.98 | 30.83 | 0.58 | -26.58 |
Exceptional items | 0 | 23.44 | -8.81 | 0 |
Net profit | 48.98 | 54.27 | -8.22 | -26.58 |
yoy growth (%) | -9.73 | -759.69 | -69.05 | 31.32 |
NPM | 8.51 | 10.54 | -2.55 | -7.48 |
Furthermore, the NPRA's recognition will enable Venus Remedies to capitalise on the expanding global demand for enoxaparin.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
Invest wise with Expert advice